
All News

Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
New Health Affairs Study: Competition In Pharmaceuticals Leads to Lower Prices, Reduced Drug Spending
A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.

One Set of Rules Means Lower Costs for Health Care
And why it matters for employer-provided coverage.
